Hybrid epicardial and endocardial ablation of persistent or permanent atrial fibrillation: A new approach for difficult cases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pak, Hui-Nam | - |
dc.contributor.author | Hwang, Chun | - |
dc.contributor.author | Lim, Hong Euy | - |
dc.contributor.author | Kim, Jin Seok | - |
dc.contributor.author | Kim, Young-Hoon | - |
dc.date.accessioned | 2021-09-09T17:09:40Z | - |
dc.date.available | 2021-09-09T17:09:40Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2007-09 | - |
dc.identifier.issn | 1045-3873 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/125723 | - |
dc.description.abstract | Epicardial AF Ablation. Background: Although percutaneous epicardial catheter ablation (PECA) has been used for the management of epicardial ventricular tachycardia, the use of PECA for atrial fibrillation (AF) has not yet been reported. Objective: To evaluate the efficacy and feasibility of a hybrid PECA and endocardial ablation for AF. Methods: We performed PECA for AF in five patients (48.6 +/- 8.1 years old, all male, four redo ablation procedures of persistent AF with a risk of pulmonary vein (PV) stenosis, one de novo ablation of permanent [AF]) after an endocardial AF ablation guided by PV potentials and 3D mapping (NavX). Utilizing an open irrigation tip catheter, a left atrial (LA) linear ablation from the roof to the perimitral isthmus or localized ablation at the junction between the LA appendage and left-sided PVs or ligament of Marshall (LOM) was performed. Results: PECA of AF was successful in all patients with an ablation time of < 15 minutes. The left-sided PV potentials were eliminated by PECA in all patients. Bidirectional block of the perimitral line was achieved in two of two patients and a left inferior PV tachycardia with conduction block to the LA was observed during the ablation in the area of the LOM in one patient. A hemopericardium developed in one patient, but was controlled successfully. During 8.0 +/- 6.3 months of follow-up, all patients have remained in sinus rhythm (four patients without antiarrhythmic drugs). Conclusion: A hybrid PECA of AF is feasible and effective in patients with redo-AF ablation procedures and at risk for left-sided PV stenosis or who are resistant to endocardial linear ablation. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | CATHETER ABLATION | - |
dc.subject | VEIN | - |
dc.title | Hybrid epicardial and endocardial ablation of persistent or permanent atrial fibrillation: A new approach for difficult cases | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jin Seok | - |
dc.identifier.doi | 10.1111/j.1540-8167.2007.00882.x | - |
dc.identifier.scopusid | 2-s2.0-34548321508 | - |
dc.identifier.wosid | 000249102100005 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, v.18, no.9, pp.917 - 923 | - |
dc.relation.isPartOf | JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | - |
dc.citation.title | JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | - |
dc.citation.volume | 18 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 917 | - |
dc.citation.endPage | 923 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | CATHETER ABLATION | - |
dc.subject.keywordPlus | VEIN | - |
dc.subject.keywordAuthor | Atrial fibrillation | - |
dc.subject.keywordAuthor | Catheter ablation | - |
dc.subject.keywordAuthor | Epicardial ablation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.